Bjorn Tore Gjertsen, Institute of Medicine, Hematology Section, Haukeland University Hospital, University of Bergen N-5021 Bergen, Norway
Biography
Bjørn Tore Gjertsen have major research interest is in development of targeted therapy and accompanying diagnostics in the aggressive blood cancer acute myeloid leukemia. His laboratory is working on intracellular signal transduction and its regulation of the tumor suppressor protein p53.
